According to the NCI website, Telaglenastat is an orally bioavailable inhibitor of glutaminase, with potential antineoplastic activity. Check for active clinical trials using this agent. (NCI Thesaurus)

Link to Drug Information Portal, a service of the U.S. National Library of Medicine, National Institutes of Health

Link to National Cancer Institute